Depletion of CD25+ cells from human T-cell enriched fraction eliminates immunodominance during priming with dendritic cells genetically modified to express a secreted protein

Cancer Gene Therapy
M MincheffHarold Meryman

Abstract

The ability of dendritic cells (DCs), genetically modified with one of two types of plasmid DNA vaccines to stimulate lymphocytes from normal human donors and to generate antigen-specific responses, is compared. The first type, also called "secreted" vaccine (sVac), encodes for the full length of the human prostate-specific antigen (PSA) with a signal peptide sequence so that the expressed product is glycosylated and directed to the secretory pathway. The second type, truncated vaccines (tVacs), encodes for either hPSA or human prostate acidic phosphatase (hPAP), both of which lack signal peptide sequences and are retained in the cytosol and degraded by the proteasomes following expression. Monocyte-derived dendritic cells are transiently transfected with either sVac or one of two tVacs. The DCs are then used to activate CD25+-depleted or nondepleted autologous lymphocytes in an in vitro model of DNA vaccination. Lymphocytes are boosted following priming with transfected DCs, peptide-pulsed DCs or monocytes. Their reactivity is tested against tumor cells or peptide-pulsed T2 target cells. Both tVacDCs and sVacDCs generate antigen-specific cytotoxic T-cell responses. The immune response is restricted towards one of the three ant...Continue Reading

References

Dec 15, 1991·Journal of Immunological Methods·P Matzinger
Oct 1, 1993·Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy·J R BenninkJ W Yewdell
Jun 24, 1998·The Journal of Clinical Investigation·D J HicklinS Ferrone
Mar 13, 1999·The Journal of Clinical Investigation·H de la SalleD Hanau
Jun 8, 1999·Annual Review of Immunology·J W Yewdell, J R Bennink
Sep 29, 1999·Immunology Today·H Groux, F Powrie
May 9, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·E L MastellerC B Thompson
Jun 3, 2000·Annual Review of Immunology·E M Shevach
Jun 8, 2001·The Journal of Experimental Medicine·E M Shevach
Jul 24, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·C A Piccirillo, E M Shevach
Oct 3, 2001·The Journal of Experimental Medicine·A M DoyleS L Reiner
Dec 12, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·L FongE G Engleman
Mar 20, 2002·Cytokine & Growth Factor Reviews·Hiroaki IkedaRobert D Schreiber
Apr 3, 2002·Seminars in Cancer Biology·H SchreiberW M Kast
Apr 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Michael J PalmowskiVincenzo Cerundolo
Oct 2, 2002·European Journal of Immunology·Claire N ManzottiDavid M Sansom
Oct 31, 2002·Nature Immunology·Gavin P DunnRobert D Schreiber
Dec 24, 2002·Nature Immunology·Shimon Sakaguchi
Jan 9, 2003·Expert Opinion on Biological Therapy·Michael A MorseH Kim Lyerly
Oct 8, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Masoud H ManjiliJohn R Subjeck
Oct 23, 2003·Seminars in Oncology·Jedd D WolchokHoward I Scher
Nov 11, 2003·Proceedings of the National Academy of Sciences of the United States of America·Masahide ToneHerman Waldmann
Nov 25, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Noelia CasaresJuan J Lasarte
Dec 4, 2003·Genes and Immunity·J D KimB S Kwon
Mar 3, 2004·European Journal of Immunology·Simona RonchettiCarlo Riccardi
Mar 24, 2004·Seminars in Immunology·Clare Baecher-AllanDavid A Hafler
Apr 7, 2004·The Journal of Experimental Medicine·Rika DraenertPhilip J R Goulder
Apr 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Namita MisraSrini V Kaveri
Apr 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Adam P KohmStephen D Miller

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.